Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 6, 2003, Pages 1654-1659

  De Deus, José M ^a   Girão, Manoel J B C ^a   Sartori, Marair G F ^a   Baracat, Edmund C ^a   Rodrigues De Lima, Geraldo ^a   Nader, Helena B ^a   Dietrich, Carl P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Estrogens progestogens; Glycosaminoglycans; Raloxifene; Rats; Urinary tract

Indexed keywords

CHONDROITIN SULFATE; CONJUGATED ESTROGEN; DERMATAN SULFATE; ESTROGEN; GESTAGEN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; MEDROXYPROGESTERONE ACETATE; RALOXIFENE;

AGAR GEL ELECTROPHORESIS; ANIMAL MODEL; ARTICLE; BLADDER; CASTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; URETHRA;

EID: 0347987977     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(03)00867-6     Document Type: Article

References (22)

1. Hurst RE, Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 1994;52:1641-4.
2. Iozzo RV. Matrix proteoglycans: from molecular, design to cellular function. Annu Rev Biochem 1998;67:609-52.
3. Parsons CL. Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation. Urology 1986;27(2 Suppl):9-14.
4. Parsons CL, Boychuck D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 1990;143:139-42.
5. Buckley MS, Washington S, Laurent C, Erickson DR, Bhavandan VP. Characterization and immunohistochemical localization of the glycoconjugates of the rabbit bladder mucosa. Arch Biochem Biophys 1996;330:163-73.
6. Lilly JD, Parsons CL. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 1990;171:493-6.
7. Kaufman JE, Anderson K, Parsons CL. Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogens. Urology 1987;30:255-8.
8. Sartori MGF, Baracat EC, Girāo MJBC, Gonçalves WJ, Sartori JP, Rodrigues de Lima G. Menopausal genuine stress urinary incontinence treated with conjugated estrogen plus progestogens. Int J Gynecol Obstet 1995;49:165-9.
9. Sartori MGF, Girāo MJBC, De Jesus Simōes M, Sartori JP, Baracat EC, Rodrigues de Lima G. Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol 2001;28:92-6.
10. Weisman K, Callahan H, Cooper HS, Fritz RW, Mulholland SG. Decrease in rabbit bladder mucosal glycoprotein after oophorectomy. J Urol 1984;132:380-3.
11. Nader HB, Ferreira TMPC, Paiva JF, Medeiros MGL, Jerônimo SMB, Paiva VMP, et al. Isolation and structural studies of heparan sulfates and chondroitin sulfates from three species of molluscs. J Biol Chem 1984;259:1431-5.
12. Hardingham TE, Adams P. A method for the determination of hyaluronate in the presence of other glycosaminoglycans and its application to human intervertebral disc. Biochem J 1976;159:143-7.
13. Judd HL, Cleary RE, Creasman WT, Figge DC, Kase N, Rosenwaks Z, et al. Estrogen replacement therapy. Obstet Gynecol 1981;58:267-75.
14. Fantl JA, Cardozo L, McLish DK. Hormones and Urogenital Therapy Committee. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis, first report of the hormones and urogenital therapy committee. Obstet Gynecol 1994;83:12-8.
15. Suguita MA, Girāo MJBC, Simōes MJ, Sartori MGF, Baracat EC, Rodrigues de Lima G. A morphologic and morphometric study of the vesical mucosa and urethra of castrated female rats following estrogen and/or progestogen replacement. Clin Exp Obstet Gynecol 2000;27:176-8.
16. Endo RM, Girāo MJBC, Sartori MGF, Simōes MJ, Baracat E, Rodrigues de Lima G. Effect of estrogen-progestogen hormonal replacement therapy in periurethral and bladder vessels. Int Urogynecol J 2000;11:120-3.
17. Russel AL. Glycosaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn's disease, interstitial cystitis and possibly Reiter's syndrome. Med Hypotheses 1999;52:297-301.
18. Parsons CL. A model for the function of glycosaminoglycans in the urinary tract. World J Urol 1994;12:38-42.
19. Hurst RE, Roy JB, Min KW, Veltri RW, Marley G, Patton K, et al. A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology 1996;48:817-21.
20. Erickson DR, Sheykhnazari M, Ordille S, Bhavanandan VP. Increased urinary hyaluronic acid and interstitial cystitis. J Urol 1998;160:1282-4.
21. Akcay T, Konukoglu D. Glycosaminoglycans excretion in interstitial cystitis. Int Urol Nephrol 1999;31:431-5.
22. Ferrara P, Rigante D, Lambert-Gardini S, Salvaggio E, Ricci R, Chiozza ML, et al. Urinary excretion of glycosaminoglycans in patients with isolated nocturnal enuresis or combined with diurnal incontinence. BJU Int 2000;86:824-5.